XML 78 R60.htm IDEA: XBRL DOCUMENT v3.7.0.1
Divestitures (Schedule of Assets Held for Sale) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 07, 2016
Dec. 31, 2016
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Pre-tax loss on divestitures     $ 268 $ (3,405) $ (496) $ 55,453 $ 51,820 $ 0 $ 0
North American OTC Healthcare | Disposal group, disposed of by sale, not discontinued operations                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Pre-tax loss on divestitures             51,800    
Cough and Cold, Dermatologicals, and Gastrointestinal products group | North American OTC Healthcare | Pediacare, New Skin and Fiber Choice | Disposal group, disposed of by sale, not discontinued operations                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Inventory $ 2,380                
Intangible assets, net 91,208                
Goodwill 2,920                
Assets sold 96,508                
Total purchase price received 42,380                
Pre-tax net (gain) on divestitures 54,128                
Costs to sell 2,018                
Pre-tax loss on divestitures $ 56,146           $ 56,146    
Cough and Cold, Dermatologicals, and Gastrointestinal products group | North American OTC Healthcare | E.P.T. and Dermoplast | Disposal group, disposed of by sale, not discontinued operations                  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                  
Inventory   $ 3,266   3,266          
Intangible assets, net   45,870   45,870          
Goodwill   6,889   6,889          
Assets sold   56,025   56,025          
Total purchase price received   59,614   $ 59,614          
Pre-tax net (gain) on divestitures   $ (3,589)